Go Pro

Meiji Yasuda Asset Management Co Ltd. Takes $6.84 Million Position in Danaher Corporation $DHR

Danaher logo with Healthcare background
Image from MarketBeat Media, LLC.

Meiji Yasuda Asset Management Co Ltd. purchased a new stake in Danaher Corporation (NYSE:DHR - Free Report) in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 9,496 shares of the conglomerate's stock, valued at approximately $6,838,000.

A number of other institutional investors have also recently added to or reduced their stakes in the stock. Clarion Wealth Managment Partners LLC acquired a new position in Danaher during the second quarter worth $590,000. Forefront Analytics LLC purchased a new position in shares of Danaher during the 2nd quarter worth $389,000. Elefante Mark B acquired a new position in shares of Danaher during the 2nd quarter valued at about $5,372,000. Matters Capital LLC acquired a new position in shares of Danaher during the 2nd quarter valued at about $226,000. Finally, Haverford Trust Co purchased a new stake in shares of Danaher in the second quarter valued at about $2,241,000. Hedge funds and other institutional investors own 79.05% of the company's stock.

Danaher Stock Performance

NYSE DHR opened at $219.42 on Monday. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.65 and a quick ratio of 1.25. Danaher Corporation has a 1-year low of $160.93 and a 1-year high of $242.80. The company has a market cap of $154.25 billion, a P/E ratio of 38.97, a P/E/G ratio of 2.72 and a beta of 0.78. The stock has a 50-day moving average of $195.80 and a two-hundred day moving average of $192.40.

Danaher (NYSE:DHR - Get Free Report) last posted its quarterly earnings data on Monday, July 20th. The conglomerate reported $1.94 earnings per share for the quarter, topping analysts' consensus estimates of $1.85 by $0.09. Danaher had a return on equity of 11.04% and a net margin of 15.95%.The business had revenue of $6.26 billion for the quarter, compared to analyst estimates of $6.12 billion. During the same quarter in the prior year, the company earned $0.77 earnings per share. The company's revenue was up 5.5% on a year-over-year basis. As a group, analysts anticipate that Danaher Corporation will post 8.53 EPS for the current year.

Analyst Ratings Changes

Several analysts have recently weighed in on the stock. Evercore reissued an "outperform" rating and issued a $230.00 price target on shares of Danaher in a research note on Monday, July 6th. Weiss Ratings upgraded Danaher from a "sell (d+)" rating to a "hold (c-)" rating in a research report on Wednesday, July 15th. Piper Sandler initiated coverage on Danaher in a research note on Thursday, June 11th. They set a "neutral" rating and a $200.00 target price for the company. Deutsche Bank Aktiengesellschaft restated a "buy" rating and issued a $240.00 target price on shares of Danaher in a research report on Wednesday, July 22nd. Finally, TD Cowen decreased their price target on Danaher from $240.00 to $236.00 and set a "buy" rating on the stock in a research note on Wednesday, July 22nd. One investment analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and five have assigned a Hold rating to the stock. Based on data from MarketBeat, Danaher currently has a consensus rating of "Moderate Buy" and an average price target of $228.91.

Check Out Our Latest Stock Report on Danaher

Danaher Profile

(Free Report)

Danaher Corporation NYSE: DHR is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher's portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

See Also

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR - Free Report).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Should You Invest $1,000 in Danaher Right Now?

Before you consider Danaher, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Danaher wasn't on the list.

While Danaher currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Stocks to Own - Summer 2026 Cover

Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines